Op. Dr.
Zeynep CİVELEK ÇAYNAK

Op. Dr.
Zeynep CİVELEK ÇAYNAK

Randevu Al
Gayrettepe Florence Nightingale Hastanesi
Özel İlgi Alanları
  • Meme Cerrahisi
  • Genel Cerrahi
    • 2011
      Gayrettepe Florence Nightingale Hastanesi
      Genel Cerrahi

      2007 - 2010
      S.B. Başakşehir Devlet Hastanesi
      Genel Cerrahi

      1995 - 1999
      Marmara Üniversitesi Tıp Fakültesi
      Genel Cerrahi Uzmanlık Eğitimi

      1993 - 1995
      Uludağ Üniversitesi Tıp Fakültesi
      Tıp Eğitimi

      • Türk Tabipler Birliği
      • Türk Cerrahi Derneği

  • Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

      • 1-  Kutanöz malin melanom'da yüksek doz interferon tedavisi. 2006-Uzmanlık tezi.
      • 2-  Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
      • Duraker N, Caynak ZC.Cancer. 2005 Aug 15;104(4):700-7.
      • 3-  Perineural invasion has no prognostic value in patients with invasive breast carcinoma.Duraker N, Caynak ZC, Türköz K.Breast. 2006 Oct;15(5):629-34.
      • 4-  Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma? Duraker N, Caynak ZC, Bati B.
      • Ann Surg Oncol. 2008 Feb;15(2):430-7. Epub 2007 Oct 3. Erratum in: Ann Surg Oncol. 2008 May;15(5):1551.
      • 5- The prognosis of tumors with only microscopic skin involvement without clinical T4b signs is significantly better than T4b tumors in breast carcinoma.
      • Duraker N, Batı B, Caynak ZC, Demir D, Kurtuluş I.Breast J. 2011 Jan-Feb;17(1):47-55.
      • 6-  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis. Duraker N, Batı B, Demir D, Caynak ZC. ISRN Oncol. 2011;2011:645450.
      • 7-  Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.Duraker N, Demir D, Bati B, Yilmaz BD, Bati Y, Çaynak ZC, Sobutay E.Jpn J Clin Oncol. 2012 Jul;42(7):601-8.
      • 8-  Lymph Node Ratio May Be Supplementary to TNM Nodal Classification in Node-positive Breast Carcinoma Based on the Results of 2151 Patients
      • Duraker N, Batı B, Caynak ZC, Demir D World Journal of Surgery, 2013 Jun;37(6):1241-8
      • 9- Axillary Lymph Node Status and Prognosis in Multifocal and Multicentric Breast CarcinomaDuraker N, Caynak ZC. The Breast Journal, 2014 Jan-Feb;20(1):61-8
      • 10- The impact of primary tumor resection on overall survival in patients with colorectal carcinoma and unresectable distatnt metastases: a prospective cohort study Duraker N, Civelek Çaynak Z, Hot Z Int J Surg. 2014;12(7):737-41
      • 11-  The prognostic value of the number of lymph nodes removed in patients with node-negative colorectal cancer
      • Duraker N, Civelek Çaynak Z, Hot Z Int J Surg. 2014 Nov1;12(12):1324-1327
      • 12- T4b ve T4d Meme Karsinomasının Klinikopatolojik Özellikler ve Prognoz Açısından Karşılaştırılması. Nüvit Duraker, Bakır Batı, Dr. Zeynep C Çaynak.
      • Ulusal Meme Hastalıkları Kongresi 2007-Sözlü sunum.
      • 13- Kolorektal Karsinomalı Erkeklerde Serbest/total Prostat Spesifik antijen oranı Nüvit Duraker, Zeynep Civelek Çaynak Didem Can Mualla Parıltı
      • Ulusal Kolon ve Rektum Cerrahisi Kongresi 2009-Sözlü sunum